{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:08:26Z","timestamp":1793275706728,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T00:00:00Z","timestamp":1515196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation for Reproductive Medicine","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"Center for Human Reproduction","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12020-017-1498-8","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T02:27:29Z","timestamp":1515205649000},"page":"661-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age"],"prefix":"10.1007","volume":"59","author":[{"given":"Norbert","family":"Gleicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly A.","family":"Kushnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Barad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,6]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, B.O. Yildiz, The prevalence and features of the polycystic ovary syndrome in an unselected patient population. J. Clin. Endocrinol. Metab. 89, 2745\u20132749 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"D. Dewailly, P. Pigny, B. Soudan, S. Catteau-Jonard, C. Decanter, E. Poncelet, A. Duhamel, Reconciling the defnition of polycystc ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentration aggregate with the markers of hyperandrogenism. J. Clin. Endocrinol. Metab. 95, 4399\u20134405 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR3","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"S. Iliodromiti, T.W. Lelsey, R.A. Anderson, S.M. Nelson, Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J. Clin. Endocrinol. Metab. 98, 3332\u20133340 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR4","unstructured":"J.K. Zawadski, A. Dunaif, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. in Polycystic Ovary Syndrome, eds. by A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam (Blackwell Scientific, Boston, MA, 1992), pp. 377\u2013384"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group, Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347 (2004)","journal-title":"Hum. Reprod."},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"R. Azziz, E. Carmine, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit et al., Position statement: criteria for defining polycystic ovary syndrome as apredominantly hyperandrogenic syndrome. An Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237\u20134245 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"C.R. McCartney, J. Marshall, Clinical practice. Polycystic ovary syndrome. N. Engl. J. Med. 375, 54\u201364 (2016)","journal-title":"N. Engl. J. Med."},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"D. Lizneva, L. Sururina, W. Walker, S. Brakta, L. Gavrilova-Jordan, R. Azziz, Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 106, 6\u201315 (2016)","journal-title":"Fertil. Steril."},{"key":"1498_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit et al., The Androgen excess and PCOS Society criteria for the polycysticovary syndrome: the complete task force report. Fertil. Steril. 91, 456\u2013488 (2009)","journal-title":"Fertil. Steril."},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1210\/jc.2011-2403","volume":"97","author":"N Gleicher","year":"2012","unstructured":"N. Gleicher, A. Kim, A. Weghofer, D.H. Barad, Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte. J. Clin. Endocrinol. Metab. 97, 995\u20131004 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1210\/jc.2013-1051","volume":"98","author":"N Gleicher","year":"2013","unstructured":"N. Gleicher, A. Kim, V. Kushnir, A. Weghofer, A. Shohat-Tal, E. Lazzaroni, H.-J. Lee, D.H. Barad, Clinical relevance of combined FSH and AMH observations in infertile women. J. Clin. Endocrinol. Metab. 98, 2136\u20132145 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jsbmb.2016.12.004","volume":"167","author":"N Gleicher","year":"2017","unstructured":"N. Gleicher, V.A. Kushnir, S.K. Darmon, A. Weghofer, Q. Wang, L. Zhang, D.F. Albertini, D. Barad, New PCOS-like phenotype in older women of likely autoimmune adrenal etiology with high AMH but low androgens. 2016. J. Steroid Biochem. Reprod. Biol. 167, 144\u2013152 (2017)","journal-title":"J. Steroid Biochem. Reprod. Biol."},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0009-2797(94)90060-4","volume":"92","author":"DM Otterness","year":"1994","unstructured":"D.M. Otterness, R. Weinshilboum, Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem. Biol. Interact. 92, 145\u2013159 (1994)","journal-title":"Chem. Biol. Interact."},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Son-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 101, 364\u2013389 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-015-0175-x","volume":"8","author":"VA Kushnir","year":"2015","unstructured":"V.A. Kushnir, N. Halevy, D.H. Barad, D.F. Albertini, N. Gleicher, Relative importance of androgen changes with aging among non-obese women with polycstic ovary syndrome. J. Ovarian Res. 8, 45 (2015)","journal-title":"J. Ovarian Res."},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1093\/humrep\/des265","volume":"27","author":"A Weghofer","year":"2012","unstructured":"A. Weghofer, A. Kim, D.H. Barad, N. Gleicher, The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum. Reprod. 27, 3287\u20133293 (2012)","journal-title":"Hum. Reprod."},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/met.2010.0039","volume":"8","author":"AA Bremer","year":"2010","unstructured":"A.A. Bremer, Polycystic ovary syndrome in the pediatric population. Metabol. Syndr. Relat. Disord. 8, 375\u2013394 (2010)","journal-title":"Metabol. Syndr. Relat. Disord."},{"key":"1498_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-9-67","volume":"9","author":"N Gleicher","year":"2011","unstructured":"N. Gleicher, D.H. Barad, Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod. Biol. Endocrinol. 9, 67 (2011)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/acel.12368","volume":"14","author":"A Ben-Meir","year":"2015","unstructured":"A. Ben-Meir, E. Burstein, A. Borrego-Alvarez, J. Chong, E. Wong, T. Yavorska, T. Naranian, M. Chi, Y. Wang, Y. Bentov, J. Alexis, J. Meriano, H.K. Sung, D.L. Gasser, K.H. Moley, S. Hekimi, R.F. Casper, A. Jurisicova, Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 14, 887\u2013895 (2015)","journal-title":"Aging Cell."},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","volume":"7","author":"N Gleicher","year":"2007","unstructured":"N. Gleicher, D. Barad, A. Weghofer, Functional autoantibodies, a new paradigm in autoimmunity? Autoimmune Rev. 7, 42\u201345 (2007)","journal-title":"Autoimmune Rev."},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1210\/en.2015-2087","volume":"157","author":"GJ Pepe","year":"2016","unstructured":"G.J. Pepe, A. Maniu, G. Aberdeen, T.J. Lynch, E.D. Albrecht, Estrogen regulation of adrenal cortical zone-specific development in the nonhuman primate impacts adrenal production of androgen and cortisol in response to ACTH in females in adulthood. Endocrinology 157, 1905\u20131913 (2016)","journal-title":"Endocrinology"},{"key":"1498_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-016-0158-9","volume":"14","author":"N Gleicher","year":"2016","unstructured":"N. Gleicher, V.A. Kushnir, A. Weghofer, D.H. Barad, The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod. Biol. Endocrinol. 14, 23 (2016)","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jsbmb.2016.01.004","volume":"158","author":"N Gleicher","year":"2016","unstructured":"N. Gleicher, K. Seier, V.A. Kushnir, A. Weghofer, Y.-G. Wu, Q. Wang, D.F. Albertini, D.H. Barad, Association between peripheral androgens and cortisol in infertile women. J. Steroid Biochem. Mol. Biol. 158, 82\u201389 (2016)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"1498_CR24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/humrep\/dex239","volume":"32","author":"A Fraissinet","year":"2017","unstructured":"A. Fraissinet, G. Robin, P. Pigny, T. Lefebvre, S. Catteau-Jonard, D. Dewailly, Use of the serum antiM\u00fcllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypical classification of polycystic ovary syndrome. Hum. Reprod. 32(8), 1716\u20131722 (2017)","journal-title":"Hum. Reprod."},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","volume":"98","author":"U Ezeh","year":"2013","unstructured":"U. Ezeh, B.O. Yildiz, R. Azziz, Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary sundrome. J. Clin. Endocrinol. Metab. 98, E1088\u2013E1096 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/JOE-14-0296","volume":"222","author":"H Prizant","year":"2014","unstructured":"H. Prizant, N. Gleicher, A. Sen, Androgen actions in the ovary: balance is key. J. Endocrinol. 222, R141\u2013R151 (2014)","journal-title":"J. Endocrinol."},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejogrb.2013.03.003","volume":"169","author":"S Garelli","year":"2013","unstructured":"S. Garelli, S. Masiero, M. Plebani, S. Chen, J. Furmaniak, D. Armanini, C. Betterle, High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 169, 248\u2013251 (2013)","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1498_CR28","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","volume":"39","author":"Y \u00c7akiroglu","year":"2016","unstructured":"Y. \u00c7akiroglu, F. Vural, B. Vural, 2016 The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J. Endocrinol. Invest. 39, 899\u2013907 (2016)","journal-title":"J. Endocrinol. Invest."},{"issue":"7","key":"1498_CR29","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/GME.0000000000000832","volume":"24","author":"ML Pan","year":"2017","unstructured":"M.L. Pan, L.R. Hen, H.M. Tsao, K.H. Chen, Polycystic ovary syndrome and the risk of subsequent primary ovarian insufficiency: a nationwide population-based study. Menopause 24(7), 803\u2013809 (2017)","journal-title":"Menopause"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1498-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1498-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T20:28:41Z","timestamp":1568406521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1498-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1498-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,6]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N.G, and D.H.B, are co-inventors on a number of pending and already awarded U.S. patents claiming therapeutic benefits from androgen supplementation in women with low functional ovarian reserve (LFOR) and relating to the FMR1 gene in a diagnostic function in female fertility. Both receive royalties from Fertility Nutraceuticals, LLC, in which N.G. also holds shares. N.G., D.H.B and V.A.K. also are co-inventors on three pending AMH-related patent applications. All authors received research grants, travel funds and speaker honoraria from Pharma companies, though none in any way related to hear presented materials. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}